Figures
- FIGURE 1
Evolution over 6 months of mucinous adenocarcinoma in a background of usual interstitial pneumonia on chest computed tomography. The cancer looks like consolidation, making early diagnosis challenging.
- FIGURE 2
a) An axial chest computed tomography (CT) image and b) a fused axial 2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET)-CT image demonstrate peripheral squamous cell cancer occurring in a patient with a “probable usual interstitial pneumonia” pattern. There is low maximum standardised uptake value (SUVmax) in fibrotic lung parenchyma compared to tumour SUVmax of 12.5.
Tables
- TABLE 1
Idiopathic pulmonary fibrosis (IPF) fulfils the five criteria set forth by the National Cancer Institute [45] and therefore qualifies as a precancerous condition
Premalignant criteria IPF Associated with an increased risk of cancer IPF has an increased risk of lung cancer When a precancer progresses to cancer, the resulting cancer arises from cells within the precancer Lung cancer arises from cells within the precancer in IPF Differs from the normal tissue from which it arises IPF differs from normal tissue from which it arises Differs from the cancer into which it develops IPF differs from the cancer into which it develops There is a method by which the precancer can be diagnosed IPF can be diagnosed by a combination of clinical, radiological and pathological features
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Why does lung cancer occur in pulmonary fibrosis?
- Is lung fibrosis a precancerous condition?
- Difference between lung cancers in fibrotic versus non-fibrotic lung
- Lung cancer screening in patients with pulmonary fibrosis
- Treatment of lung cancer in patients with pulmonary fibrosis
- Conclusion
- Footnotes
- References
- Figures & Data
- Info & Metrics